1r6g

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: 200px<br /> <applet load="1r6g" size="450" color="white" frame="true" align="right" spinBox="true" caption="1r6g, resolution 3.00&Aring;" /> '''Crystal structure o...)
Line 1: Line 1:
-
[[Image:1r6g.gif|left|200px]]<br />
+
[[Image:1r6g.gif|left|200px]]<br /><applet load="1r6g" size="350" color="white" frame="true" align="right" spinBox="true"
-
<applet load="1r6g" size="450" color="white" frame="true" align="right" spinBox="true"
+
caption="1r6g, resolution 3.00&Aring;" />
caption="1r6g, resolution 3.00&Aring;" />
'''Crystal structure of the thyroid hormone receptor beta ligand binding domain in complex with a beta selective compound'''<br />
'''Crystal structure of the thyroid hormone receptor beta ligand binding domain in complex with a beta selective compound'''<br />
==Overview==
==Overview==
-
A set of thyromimetics having improved selectivity for TR-beta1 were, prepared by replacing the 3'-isopropyl group of 2 and 3 with substituents, having increased steric bulk. From this limited SAR study, the most potent, and selective compounds identified were derived from 2 and contained a, 3'-phenyl moiety bearing small hydrophobic groups meta to the biphenyl, link. X-ray crystal data of 15c complexed with TR-beta1 LBD shows, methionine 442 to be displaced by the bulky R3' phenyl ethyl amide side, chain. Movement of this amino acid side chain provides an expanded pocket, for the bulky side chain while the ligand-receptor complex retains full, agonist activity.
+
A set of thyromimetics having improved selectivity for TR-beta1 were prepared by replacing the 3'-isopropyl group of 2 and 3 with substituents having increased steric bulk. From this limited SAR study, the most potent and selective compounds identified were derived from 2 and contained a 3'-phenyl moiety bearing small hydrophobic groups meta to the biphenyl link. X-ray crystal data of 15c complexed with TR-beta1 LBD shows methionine 442 to be displaced by the bulky R3' phenyl ethyl amide side chain. Movement of this amino acid side chain provides an expanded pocket for the bulky side chain while the ligand-receptor complex retains full agonist activity.
==Disease==
==Disease==
Line 11: Line 10:
==About this Structure==
==About this Structure==
-
1R6G is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with 442 as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1R6G OCA].
+
1R6G is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=442:'>442</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1R6G OCA].
==Reference==
==Reference==
Line 19: Line 18:
[[Category: Dejneka, T.]]
[[Category: Dejneka, T.]]
[[Category: Devasthale, P.]]
[[Category: Devasthale, P.]]
-
[[Category: Doweyko, A.M.]]
+
[[Category: Doweyko, A M.]]
[[Category: Einspahr, H.]]
[[Category: Einspahr, H.]]
[[Category: Farnegardh, M.]]
[[Category: Farnegardh, M.]]
-
[[Category: Friends, T.J.]]
+
[[Category: Friends, T J.]]
[[Category: Grynfarb, M.]]
[[Category: Grynfarb, M.]]
-
[[Category: Hangeland, J.J.]]
+
[[Category: Hangeland, J J.]]
[[Category: Husman, B.]]
[[Category: Husman, B.]]
[[Category: Koehler, K.]]
[[Category: Koehler, K.]]
Line 30: Line 29:
[[Category: Malm, J.]]
[[Category: Malm, J.]]
[[Category: Mellstrom, K.]]
[[Category: Mellstrom, K.]]
-
[[Category: Ryono, D.E.]]
+
[[Category: Ryono, D E.]]
-
[[Category: Sack, J.S.]]
+
[[Category: Sack, J S.]]
[[Category: Sandberg, J.]]
[[Category: Sandberg, J.]]
[[Category: Sheppard, C.]]
[[Category: Sheppard, C.]]
Line 37: Line 36:
[[Category: alpha helical]]
[[Category: alpha helical]]
-
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 19:00:34 2007''
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:47:34 2008''

Revision as of 12:47, 21 February 2008


1r6g, resolution 3.00Å

Drag the structure with the mouse to rotate

Crystal structure of the thyroid hormone receptor beta ligand binding domain in complex with a beta selective compound

Contents

Overview

A set of thyromimetics having improved selectivity for TR-beta1 were prepared by replacing the 3'-isopropyl group of 2 and 3 with substituents having increased steric bulk. From this limited SAR study, the most potent and selective compounds identified were derived from 2 and contained a 3'-phenyl moiety bearing small hydrophobic groups meta to the biphenyl link. X-ray crystal data of 15c complexed with TR-beta1 LBD shows methionine 442 to be displaced by the bulky R3' phenyl ethyl amide side chain. Movement of this amino acid side chain provides an expanded pocket for the bulky side chain while the ligand-receptor complex retains full agonist activity.

Disease

Known diseases associated with this structure: Thyroid hormone resistance OMIM:[190160], Thyroid hormone resistance, autosomal recessive OMIM:[190160]

About this Structure

1R6G is a Single protein structure of sequence from Homo sapiens with as ligand. Full crystallographic information is available from OCA.

Reference

Thyroid receptor ligands. Part 2: Thyromimetics with improved selectivity for the thyroid hormone receptor beta., Hangeland JJ, Doweyko AM, Dejneka T, Friends TJ, Devasthale P, Mellstrom K, Sandberg J, Grynfarb M, Sack JS, Einspahr H, Farnegardh M, Husman B, Ljunggren J, Koehler K, Sheppard C, Malm J, Ryono DE, Bioorg Med Chem Lett. 2004 Jul 5;14(13):3549-53. PMID:15177471

Page seeded by OCA on Thu Feb 21 14:47:34 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools